343 related articles for article (PubMed ID: 32000989)
1. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy].
Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989
[TBL] [Abstract][Full Text] [Related]
2. [Early efficacy of dexamethasone implant (OZURDEX
Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
[TBL] [Abstract][Full Text] [Related]
3. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A;
Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
[TBL] [Abstract][Full Text] [Related]
5. [Real life retrospective study of 98 eyes treated with intravitreal dexamethasone or anti-VEGF injections for macular edema due to diabetes or retinal vein occlusion].
Routier M; Ducloyer JB; Masse H; Lebreton O; Fossum P; Clement M; Weber M
J Fr Ophtalmol; 2021 Oct; 44(8):1148-1158. PubMed ID: 34353656
[TBL] [Abstract][Full Text] [Related]
6. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results.
Busch C; Fraser-Bell S; Iglicki M; Lupidi M; Couturier A; Chaikitmongkol V; Giancipoli E; Rodríguez-Valdés PJ; Gabrielle PH; Laíns I; Santos AR; Cebeci Z; Amphornphruet A; Degenhardt V; Unterlauft JD; Cagini C; Mané-Tauty V; D'Amico Ricci G; Hindi I; Agrawal K; Chhablani J; Loewenstein A; Zur D; Rehak M;
Acta Diabetol; 2019 Dec; 56(12):1341-1350. PubMed ID: 31541334
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience.
Mello Filho P; Andrade G; Maia A; Maia M; Biccas Neto L; Muralha Neto A; Moura Brasil O; Minelli E; Dalloul C; Iglicki M
Ophthalmologica; 2019; 241(1):9-16. PubMed ID: 30408801
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema.
Matonti F; Pommier S; Meyer F; Hajjar C; Merite PY; Parrat E; Rouhette H; Rebollo O; Guigou S
Eur J Ophthalmol; 2016 Aug; 26(5):454-9. PubMed ID: 27079207
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
[TBL] [Abstract][Full Text] [Related]
11. [Multicenter Ozurdex® assessment for diabetic macular edema: MOZART study].
Guigou S; Hajjar C; Parrat E; Merite PY; Pommier S; Matonti F; Prost-Magnin O; Meyer F
J Fr Ophtalmol; 2014 Jun; 37(6):480-5. PubMed ID: 24813119
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.
Mathis T; Lereuil T; Abukashabah A; Voirin N; Sudhalkar A; Bilgic A; Denis P; Dot C; Kodjikian L
Acta Diabetol; 2020 Dec; 57(12):1413-1421. PubMed ID: 32656710
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight Registries.
Tessier M; Meillon C; Creuzot-Garcher C; Bron AM; Nguyen P
J Fr Ophtalmol; 2020 Sep; 43(7):618-625. PubMed ID: 32473741
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
Totan Y; Güler E; Gürağaç FB
Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
[TBL] [Abstract][Full Text] [Related]
16. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema.
Esen E; Sizmaz S; Demircan N
Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study.
Menezo M; Roca M; Menezo V; Pascual I
Curr Med Res Opin; 2019 Dec; 35(12):2111-2116. PubMed ID: 31378087
[No Abstract] [Full Text] [Related]
19. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
